Cardiovascular clinicians world-wide require evidence-based general cardiology courses that incorporate rigorous science with clinically current and emerging approaches to cardiovascular disease risk management. The American College of Cardiology responds to this need by offering the New York Cardiovascular Symposium.
Join world-renowned cardiologist and course director, Valentin Fuster, MD, PhD, MACC and his team of expert presenters for thought-provoking topics including the year's ground-breaking scientific advances, their clinical practice applications and how the future of cardiovascular medicine will improve patient care.
Saturday, December 8, 2018
Session VII: Valvular Heart Disease and Aorta — Challenges in 2018 Management of Aortic Valve Disease and Aorta
1:50 p.m. Severe Aortic Valvular Stenosis — TVAR in 4 Ages and 4 Etiologies Age 25y Congenital, 50y Bicuspid, 75y Rheumatic, 100y Degenerative - Discussant: David H. Adams, MD
2:30 p.m. The Dilated Thoracic & Abdominal Aorta and Complicating Dissection Evolving Understanding of the Basic Biology & Management - Discussant: David H. Adams, MD
3:00 p.m. Valvular Heart Disease and Aorta - Challenges in 2018, Panel Discussion - Drs. Bonow, Sharma, O'Gara, Adams, Fuster, and Nishimura
Session VIII: Management of Mitral Regurgitation, Tricuspid Regurgitation and Hypertrophic Cardiomyopathy
3:40 p.m. Significant Mitral Regurgitation (Low EF, LVEdD, PH or AF) 2 Etiologies (1ary, 2ary), 3 Approaches (Medical, T. Clipping, Surgical) - David H. Adams, MD, Discussant: Dr. Sharma
4:05 p.m. Significant Tricuspid Regurgitation (2ary, 1ary), 3 Approaches (Medical, T. Coaptation or Suturing, Surgical) - Discussant: David H. Adams, MD
4:55 p.m. Management of Mitral Regurgitation, Tricuspid Regurgitation and Hypertrophic Cardiomyopathy Panel Discussion - Drs. Adams, Sharma and Nishimura